CHRDL1 anticorps (N-Term)
Aperçu rapide pour CHRDL1 anticorps (N-Term) (ABIN951513)
Antigène
Voir toutes CHRDL1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 5-35, N-Term
-
Specificité
- This antibody recognizes CHRDL1 / NRLN1.
-
Réactivité croisée (Details)
- Species reactivity (tested):Human
-
Purification
- Purified through a Protein A column followed by peptide affinity purification
-
Immunogène
- Synthetic peptide - KLH conjugated - corresponding to the N-terminal region (between 5-35aa) of human CHRDL1 / NRLN1
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) Sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- CHRDL1 (Chordin-Like 1 (CHRDL1))
-
Autre désignation
- CHRDL1 / NRLN1
-
Sujet
- CHRDL1 is an antagonist of bone morphogenetic protein 4. The encoded protein may play a role in topographic retinotectal projection and in the regulation of retinal angiogenesis in response to hypoxia. Alternatively spliced transcript variants encoding different isoforms have been described.Synonyms: Chordin-like protein 1, Neuralin-1, Neurogenesin-1, Ventroptin
-
ID gène
- 91851
-
NCBI Accession
- NP_001137453
Antigène
-